首页> 外文期刊>Virology >Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120
【24h】

Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120

机译:HIV-1包膜糖蛋白gp120抗体抑制DC-SIGN与HIV-1 gp120相互作用的效力

获取原文
获取原文并翻译 | 示例
       

摘要

The interaction of DC-SIGN with gp120 provides an attractive target for intervention of HIV-1 transmission. Here, we have investigated the potency of gp120 antibodies to inhibit the DC-SIGN-gp120 interaction. We demonstrate that although the V3 loop is not essential for DC-SIGN binding, antibodies against the V3 loop partially inhibit DC-SIGN binding, suggesting that these antibodies sterically hinder DC-SIGN binding to gp120. Polyclonal antibodies raised against non-glycosylated gp120 inhibited both low and high avidity DC-SIGN-gp120 interactions in contrast to polyclonal antibodies raised against glycosylated gp120. Thus, glycans present on gp120 may prevent the generation of antibodies that block the DC-SIGN-gp 120 interactions. Moreover, the polyclonal antibodies against non-glycosylated gp120 efficiently inhibited HIV-1 capture by both DC-SIGN transfectants and immature dendritic cells. Therefore, non-glycosylated gp120 may be an attractive immunogen to elicit gp120 antibodies that block the binding to DC-SIGN. Furthermore, we demonstrate that DC-SIGN binding to gp120 enhanced CD4 binding, suggesting that DC-SIGN induces conformational changes in gp120, which may provide new targets for neutralizing antibodies. (C) 2004 Elsevier Inc. All rights reserved.
机译:DC-SIGN与gp120的相互作用为HIV-1传播的干预提供了一个有吸引力的目标。在这里,我们研究了gp120抗体抑制DC-SIGN-gp120相互作用的效力。我们证明,尽管V3环对于DC-SIGN结合不是必需的,但针对V3环的抗体部分抑制了DC-SIGN结合,这表明这些抗体在空间上阻碍了DC-SIGN与gp120的结合。与针对糖基化gp120的多克隆抗体相反,针对非糖基化gp120的多克隆抗体抑制了低亲和力和高亲和力DC-SIGN-gp120相互作用。因此,存在于gp120上的聚糖可能会阻止抗体产生,从而阻止DC-SIGN-gp 120相互作用。此外,针对非糖基化gp120的多克隆抗体可有效抑制DC-SIGN转染子和未成熟树突状细胞对HIV-1的捕获。因此,非糖基化的gp120可能是引诱阻断与DC-SIGN结合的gp120抗体的诱人免疫原。此外,我们证明了DC-SIGN与gp120的结合增强了CD4的结合,表明DC-SIGN在gp120中诱导构象变化,这可能为中和抗体提供新的靶点。 (C)2004 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号